Congressional Stock Trades & Disclosures
Chris Jacobs is a U.S. Representative, a Republican representing NY. As of January 2023, Bullish Whales has tracked 299 disclosed stock trades across 144 companies, representing $6.3M in disclosed transaction value, each filed publicly under the STOCK Act.
About Jacobs's congressional trading
Jacobs's disclosed activity shows a sell-leaning pattern, with 141 purchases and 155 sales (a buy-to-sell ratio of 0.91). Jacobs has traded --, HD, and CVX most frequently among disclosed positions.
Jacobs's most recent disclosed trade was a purchase of First Horizon Corporation (FHN) from December 2022. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Estimated trading profits
No priced buy disclosures in this window.
No priced buy disclosures in this window.
Based on 92 of 115 disclosed buys with pricing coverage.
Dec 28, 2020 to Jul 14, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 FHNFirst Horizon Corporation | Buy | $1,001 - $15,000 | 12 DEC 2022 | $21.58 | +19.18% |
 DOCHealthpeak Properties Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | $19.32 | +12.10% |
 NTSTNetstreit Corp | Buy | $1,001 - $15,000 | 12 DEC 2022 | $16.27 | +31.51% |
 XPROExpro Group Holdings NV | Sell | $1,001 - $15,000 | 12 DEC 2022 | $15.26 | +7.14% |
 AROCArchrock Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | $7.30 | +427.53% |
 HLXHelix Energy Solutions Group Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | $6.04 | +57.78% |
 JPMJPMorgan Chase & Co | Sell | $1,001 - $15,000 | 12 DEC 2022 | $123.46 | +177.74% |
 PFEPfizer Inc | Sell | $1,001 - $15,000 | 12 DEC 2022 | $42.43 | -42.84% |
 CMTGClaros Mortgage Trust Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | $17.44 | -86.81% |
 KALVKalvista Pharmaceuticals Inc | Buy | $1,001 - $15,000 | 12 DEC 2022 | $5.91 | — |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Chris Jacobs congressional trading FAQ
Can Chris Jacobs legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Chris Jacobs's disclosures so the public can review them.
Where does Quantellect get Chris Jacobs's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Chris Jacobs's stock trades?
Quantellect tracks every stock trade Chris Jacobs discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Chris Jacobs disclosed?
Quantellect has tracked 299 disclosed trades by Chris Jacobs across 144 companies.
Which stocks does Chris Jacobs trade most?
Chris Jacobs's most frequently disclosed positions include --, HD, CVX, SAVA, and TELL. The full list of companies and individual filings is shown on this page.
What was Chris Jacobs's most recent stock trade?
Chris Jacobs most recently bought First Horizon Corporation (FHN) in December 2022, according to public STOCK Act filings tracked by Quantellect.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.